Global Aromatase Deficiency Market – Global Industry Trends & Forecast to 2029

 

The  Global Aromatase deficiency market was valued at USD 90.45 million in 2021 and is expected to reach USD 109.35 million by 2029, registering a CAGR of 2.40% during the forecast period of 2022 to 2029. 

 

Aromatase Deficiency Market Dynamics

Drivers

  • Rise in the number of cases of aromatase deficiency

Aromatase deficiency is a sexual development condition characterized by low estrogen levels and high testosterone leels. Because of excessive growth of long bones in the arms and legs, affected people are abnormally tall.

  • Increasing investment for healthcare infrastructure

Another significant factor influencing the growth rate of aromatase deficiency market is the rising healthcare expenditure which helps in improving its infrastructure. Also, various government organizations aims to improve the healthcare infrastructure by increasing funding and this will further influence the market dynamics.

Opportunities

  • Increase in the number of research and development activities       

Moreover, the market's growth is fueled by an increase in the number of research and development activities. This will provide beneficial opportunities for the aromatase deficiency market growth.

Restraints/Challenges

On the other hand, high cost associated with the treatment as well as diagnosis will obstruct the growth rate of market. The lack of healthcare infrastructure in developing economies and dearth of skilled professionals will challenge the aromatase deficiency market. Additionally, lack of awareness among people and unfavourable healthcare policies will act as restrain and further impede the growth rate of market during the forecast period of 2022-2029.

Patient Epidemiology Analysis

Aromatase deficiency market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report.

 

Market Definition

 Aromatase deficiency is an uncommon condition that affects the synthesis of estradiol, causing hirsutism in pregnant women, pseudohermaphroditism and virilization in women, and tall height, osteoporosis, and obesity in men. Female patients may be candidates for surgical genitalia modification depending on the degree of ambiguity, and ovarian cysts must be monitored. After puberty, daily estrogen treatment (0.625 mg/twice weekly increasing to daily) is required, which can be augmented with progesterone-like hormone and monthly gonadotrophin-releasing hormone antagonist therapies.

 

Global Aromatase Deficiency Market Scope

The aromatase deficiency market is segmented on the basis of diagnosis, treatment, route of administration, age of onset, end-users and distribution channel.

Diagnosis

  • Physical Examination
  • Gene Sequencing
  • Genetic testing
  • Others

Treatment

  • Surgery
  • Estrogen Replacement
  • Others

Age of Onset

  • Pediatrics
  • Adults
  • Geriatrics

Route of Administration

  • Oral
  • Parenteral
  • Others

End-Users

  • Hospitals
  • Specialty Clinics
  • Homecare
  • Others

Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Others

Get sample report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-aromatase-deficiency-market

 

Competitive Landscape and Aromatase Deficiency Market Share Analysis

Some of the major players operating in the aromatase deficiency market are:

  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Mylan N.V. (US)
  • Sanofi (France)
  • Pfizer Inc. (US)
  • GlaxoSmithKline plc (UK)
  • Novartis AG (Switzerland)
  • Abbott (US)
  • Merck KGaA (Germany)
  • Novo Nordisk A/S (Denmark)
  • Genentech Inc. (US)
  • Amgen Inc. (US)
  • Endo International plc (Ireland)

 

Get toc report @ https://www.databridgemarketresearch.com/toc/?dbmr=global-aromatase-deficiency-market

 

MAJOR TOC OF THE REPORT

Ø  Chapter One: Introduction

Ø  Chapter Two: Market Dynamics

Ø  Chapter Three: Market Definition

Ø  Chapter Four: Market Scope

Ø  Chapter Five: Market Share Analysis

 

Get Full  Details: https://www.databridgemarketresearch.com/reports/global-aromatase-deficiency-market

 

Browse Related Reports

Global Laboratory Information Systems (LIS) Market

Global Postoperative Management Market

Global Point-of-Care Testing (POCT) Market 

 

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: Sopan.gedam@databridgemarketresearch.com

 

 

Comments

Post a Comment

Popular posts from this blog

E-Clinical Solutions Market Growth Global health Infrastructure

   E-Clinical Solutions Market Dynamics Drivers Upsurge in the research and development proficiencies Increasing R&D expenditure on drug development Significant growth in the biopharmaceutical industries Opportunities Growing clinical research activities and government support in emerging economies Rising government grants and financing for clinical trials Restraints/Challenges High costs and risks associated with developing new therapeutics High capital cost coupled with periodic maintenance costs Global E-Clinical Solutions Market Scope Product Electronic Data Capture (EDC) & Clinical Data Management Systems (CDMS) Clinical Trial Management Systems (CTMS) Electronic Clinical Outcome Assessment (eCOA) Randomization and Trial Supply Management Solution (RTMS) Safety Solutions Analytics and Reporting Platforms Integration Platforms Delivery Mode ...
Read more

Asia-Pacific Sternal Closure Systems Market Share, Demand, Top Players, Industry Size, Revenue Analysis, Top Leaders and Forecast 2029

Image
  Data Bridge Market Research analyses that the Asia-Pacific sternal closure systems market to be grow at a CAGR of 6.9% in the forecast period of 2022-2029 and is likely to reach the USD 551.06 million by 2029. Asia-Pacific Sternal Closure Systems business report gives explanation about the vital developments in the market which range from the crucial improvements of the market, containing research and development, new item dispatch, pronouncement, coordinated efforts, associations, joint aspire, and territorial development of the key rivals working in the market on a global and local scale. Furthermore, the report also estimates essential market features that comprises of revenue (USD), price (USD), capacity utilization rate, production value, production rate, consumption, import-export, supply-demand analysis, cost, market share, gross margin and market CAGR value. Such a wide range of market parameters make an international Asia-Pacific Sternal Closure Systems market researc...
Read more